Advanced Cell Technology to Present at 15th Annual BIO CEO & Investor Conference

  Advanced Cell Technology to Present at 15th Annual BIO CEO & Investor
  Conference

BIO CEO & Investor Conference 2013

Business Wire

MARLBOROUGH, Mass. -- February 8, 2013

Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of
regenerative medicine, announced today that chairman and CEO Gary Rabin will
present at the 15^th Annual BIO CEO & Investor Conference, taking place
February 11-12 at the Waldorf Astoria in New York City.

A webcast of Mr. Rabin’s presentation will be available beginning
approximately one hour after the conclusion of Mr. Rabin’s live presentation;
link below. The Company’s PowerPoint presentation will be available on the
Presentations section of the ACT website.

The following are specific details regarding ACT’s presentation:

BIO CEO & Investor Conference

Date of Presentation: Monday, February 11

Time: 10:00 a.m. EST

Location: Conrad Room
         Waldorf Astoria Hotel
         301 Park Ave, New York, NY 10022

Webcast link:
http://www.veracast.com/webcasts/bio/ceoinvestor2013/19106184.cfm

(Registration required; webcast will be available approximately one hour after
presentation concludes.)

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc., is a biotechnology company applying cellular
technology in the field of regenerative medicine. For more information, visit
www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating
results, future growth in research and development programs, potential
applications of our technology, opportunities for the company and any other
statements about the future expectations, beliefs, goals, plans, or prospects
expressed by management constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any
statements that are not statements of historical fact (including statements
containing the words “will,” “believes,” “plans,” “anticipates,” “expects,”
“estimates,” and similar expressions) should also be considered to be
forward-looking statements. There are a number of important factors that could
cause actual results or events to differ materially from those indicated by
such forward-looking statements, including: limited operating history, need
for future capital, risks inherent in the development and commercialization of
potential products, protection of our intellectual property, and economic
conditions generally. Additional information on potential factors that could
affect our results and other risks and uncertainties are detailed from time to
time in the company’s periodic reports, including the report on Form 10-K for
the year ended December 31, 2011. Forward-looking statements are based on the
beliefs, opinions, and expectations of the company’s management at the time
they are made, and the company does not assume any obligation to update its
forward-looking statements if those beliefs, opinions, expectations, or other
circumstances should change. Forward-looking statements are based on the
beliefs, opinions, and expectations of the company’s management at the time
they are made, and the company does not assume any obligation to update its
forward-looking statements if those beliefs, opinions, expectations, or other
circumstances should change. There can be no assurance that the Company’s
clinical trials will be successful.

Contact:

Investors:
CEOcast, Inc.
James Young, 212-732-4300
or
Press:
ACT Corporate Communications
Bill Douglass, 646-450-3615
or:
Russo Partners
Martina Schwarzkopf, Ph.D., 212-845-4292